Reviewed by MedNext Clinical Team
Despite the availability of direct oral anticoagulants (DOACs), warfarin remains an important drug in clinical practice. Many patients with mechanical heart valves, antiphospholipid syndrome, or established warfarin tolerance continue on this vitamin K antagonist. Effective management requires understanding its narrow therapeutic index and extensive interaction profile [1].
Target INR Ranges by Indication
The target INR varies by clinical indication. For atrial fibrillation and venous thromboembolism, the target range is typically 2.0–3.0. Patients with mechanical heart valves require a higher target of 2.5–3.5, with the precise target depending on valve type and position [1]. Patients and clinicians must be clear about the specific target for each individual to avoid both under- and over-anticoagulation.
Food and Dietary Interactions
Vitamin K is the most important dietary factor affecting warfarin. Foods high in vitamin K — including leafy green vegetables such as spinach, kale, and broccoli — reduce warfarin's anticoagulant effect. The key message for patients is not to avoid these foods entirely, but to maintain a consistent intake. Sudden large increases in vitamin K consumption will raise INR instability.
Cranberry and Alcohol
Cranberry juice has been reported to potentiate warfarin's effect, likely through CYP2C9 inhibition, and patients should be advised to limit intake. Alcohol has a variable effect: moderate consumption may cause modest INR elevation, while chronic heavy drinking induces hepatic enzymes and can reduce warfarin efficacy and cause unpredictable INR fluctuations.
Drug Interactions
Warfarin interacts with an enormous number of drugs. Antibiotics are among the most clinically significant — broad-spectrum antibiotics reduce gut flora that produce vitamin K2, potentiating warfarin. Metronidazole and fluconazole inhibit CYP2C9 and can cause dangerous INR elevation. NSAIDs increase bleeding risk through gastric mucosal effects and platelet inhibition. Amiodarone is a potent inhibitor of warfarin metabolism and typically requires significant dose reduction [1].
Managing Over-Anticoagulation
For INR above target without bleeding, withholding one or two doses is usually sufficient. For INR above 5.0, low-dose oral vitamin K (1–2.5 mg) is appropriate. Major or life-threatening bleeding requires urgent reversal with intravenous vitamin K and a four-factor prothrombin complex concentrate (PCC). Fresh frozen plasma is a less preferred alternative due to volume requirements and slower correction.
References
- Holbrook AM, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165:1095-1106.